ANGPTL4 and Lymphadenopathy: However, the development of lymphadenopathies are not observed in mice with ANGPTL4 liver specific knockout 47 or adipose tissue-specific knockout48, suggesting that tissue-specific targeting of ANGPTL4 may not display this side effect.